Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia
暂无分享,去创建一个
C. Dearden | Jian-yong Li | J. Burger | A. Tedeschi | T. Robak | O. Bairey | S. Coutre | F. Offner | P. Ghia | C. Owen | P. Barr | P. Hillmen | Cathy Zhou | T. Kipps | H. McCarthy | S. Grosicki | A. Szőke | C. Moreno | E. Hsu | A. Szoke